NAFLD
Metabolic Diseases
5
Pipeline Programs
11
Companies
6
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
3
0
0
1
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Peptide
1100%
+ 5 programs with unclassified modality
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Vedanta BiosciencesMA - Cambridge
1 program1
Gut microbiome transplantationPhase 41 trial
Active Trials
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program1
Semaglutide Pen InjectorPhase 2Peptide1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Vedanta BiosciencesGut microbiome transplantation
NeuralyDD01
Novo NordiskSemaglutide Pen Injector
IpsenElobixibat
Bristol Myers SquibbBMS-986036
PfizerFollow-up
Clinical Trials (6)
Total enrollment: 1,157 patients across 6 trials
The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD)
Start: Dec 2019Est. completion: Dec 202120 patients
Phase 4Unknown
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH
Start: Jun 2024Est. completion: Jun 2026
Phase 2Active Not Recruiting
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
Start: Feb 2024Est. completion: Feb 202650 patients
Phase 2Recruiting
A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH
Start: Jun 2019Est. completion: Jul 202047 patients
Phase 2Completed
An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function
Start: Sep 2018Est. completion: Jun 201940 patients
Phase 1Completed
Risk Factors for Advanced Fibrosis Among FLD Patients
Start: Aug 2023Est. completion: Dec 20251,000 patients
N/AUnknown
Related Jobs in Metabolic Diseases
Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV
Amgen
California - San Francisco, US
20h ago
(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)
Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday
Computational Chemist
Topos Bio
San Francisco Office
2d ago
Associate Director, Legal Operations & Contracts Management
Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr
Senior Specialist, Quality Management Systems
Crinetics Pharmaceuticals
San Diego, CA
4d ago
$91K - $114K/yr
Director, Quality Systems, Project Management, QRM, RS
Crinetics Pharmaceuticals
US California
4d ago
$178K - $223K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,157 patients
11 companies competing in this space